Podcasts

PODCAST | The More Data We Have, the Better – CBER Director, US FDA

avatar

Written by: CDO Magazine

Updated 11:45 AM EST, January 4, 2024

post detail image

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), speaks with Chris Houchin, Partner at Guidehouse, in a video interview about the challenges and opportunities of using data sets for rare disease treatment, using decentralized trials, and the possibility of leveraging real-world evidence for cell and gene therapies, and partnering with the FDA.

Related Stories

September 17, 2026  |  In Person

Chicago Leadership Summit

Renaissance Chicago Downtown Hotel

Similar Topics
Artificial Intelligence
Data Management
Diversity
Testimonials
background imagebackground image
Community Network

Join Our Community

starElevate Your Personal Brand

starShape the Data Leadership Agenda

starBuild a Lasting Network

starExchange Knowledge & Experience

starStay Updated & Future-Ready

logo
Social media icon
Social media icon
Social media icon
Social media icon
About